We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The Phase III clinical of Butylphthalide Soft Capsules(Trade name: NBP)for the treatment of vascular dementia was officially approved by the Genetics Office in China.